P536: A FIRST‐IN‐HUMAN PHASE 1 STUDY OF IO‐202 (ANTI‐LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
Dinardo, Courtney, Pollyea, Daniel, Aribi, Ahmed, Jonas, Brian, Jeyakumar, Deepa, Roboz, Gail, Liu, Hongtao, Dunavin, Neil, Blum, William, Zhang, Alec, Tabata, Yasuhiro, Valencia, Donna, Huang, Tao, Hong, Kyu, Xiang, Hong, Liao, Charlene, Woodard, Paul, Madanat, Yazan
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
eP259: A phase 1/2 trial of AXO-AAV-GM1 gene therapy for the treatment of infantile- and juvenile-onset GM1 gangliosidosis
Tift, Cynthia, D'Souza, Precilla, Johnston, Jean, Acosta, Maria, Nicoli, Elena-Raluca, Rothermel, Caroline, Thurm, Audrey, Karunakara, Ajith, Thorp, Benjamin, Ross, Peter, Jameson, John, Sheehan, Michael, Vaughn, Toby, Valencia, Donna, De Boever, Erika
Published in Genetics in medicine (01.03.2022)
Published in Genetics in medicine (01.03.2022)
Get full text
Journal Article
Phase 1/2 trial of AXO-AAV-GM1 (AAV9-GLB1) gene therapy for infantile- and juvenile-onset GM1 gangliosidosis
Tifft, Cynthia, D’Souza, Precilla, Johnston, Jean M., Acosta, Maria T., Nicoli, Elena-Raluca, Rothermel, Caroline, Thurm, Audrey, Karunakara, Ajith, Thorp, Benjamin, Ross, Peter, Jameson, John, Sheehan, Michael, Vaughn, Toby, Valencia, Donna, De Boever, Erika, Corcoran, Gavin
Published in Molecular genetics and metabolism (01.02.2022)
Published in Molecular genetics and metabolism (01.02.2022)
Get full text
Journal Article
Abstract CT040: A first-in-human phase 1 trial of IO-108, an antagonist antibody targeting LILRB2 (ILT4), as monotherapy and in combination with pembrolizumab in adult patients with advanced relapsed or refractory solid tumors: Dose escalation study
Taylor, Matthew H., Patel, Manish R., Powderly, John D., Woodard, Paul, Chung, Luke, Tian, Hongyu, Hong, Xiang, Hong, Kyu, Valencia, Donna, Huang, Tao, Schebye, Xiao Min, Liao, Charlene, Naing, Aung
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article